Summary
Accumulating evidence indicates that multiple sclerosis, a chronic inflammatory disease of the central nervous system, has an autoimmune origin. Since T cells reactive to myelin basic protein (MBP) are thought to play an important role in the pathogenesis of this disease, it was assumed that inactivation or depletion of this pathogenic T cell subset may have therapeutic effects in multiple sclerosis. We have recently reported that T cell vaccination, i.e. immunisation with attenuated autologous MBP-reactive T cell clones, leads to the depletion of the MBP-reactive T cells. Furthermore, this approach induced favourable clinical effects in the treated patients, encouraging further studies of T cell vaccination in multiple sclerosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stinissen P, Raus J, Zhang J. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol 1996. In press
Hafler DA, Weiner HL. MS: a CNS and systemic autoimmune disease. Immunol Today 1989; 10: 104–7
Zhang J, Markovic S, Lacet B, et al. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994; 179: 973–84
Wucherpfennig KW, Weiner HL, Hafler DA. T cell recognition of myelin basic protein. Immunol Today 1991; 12: 277
Wucherpfennig KW, Zhang J, Witek C, et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 1994; 152: 5581–92
Vandevyver C, Mertens N, van den Elsen P, et al. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 1995; 25: 958–68
Steinman L. The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease. Adv Immunol 1991; 49: 357–79
Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990; 8: 579
Ben-Nun A, Wekerle H, Cohen IR. Vaccination against autoimmune encephalomyelitis with T lymphocyte line cells reactive against myelin basic protein. Nature 1981; 292: 60–1
Lider O, Reshef T, Beraud E, et al. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 1988; 239: 181–3
Vandenbark AA, Hashim GA, Offner H. Immunization with a synthetic T cell receptor V region peptide protects against experimental autoimmune encephalomyelitis. Nature 1989; 341: 541–4
Sun D, Qin Y, Chluba J, et al. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T interactions. Nature 1988; 332: 437–53
Zhang JW, Medaer R, Stinissen P, et al. MHC restricted clonotypic depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 1993; 261: 1451–4
Zhang J, Vandevyver C, Stinissen P, et al. In vivo clonotypic regulation of human myelin basic protein reactive T cells by T cell vaccination. J Immunol 1995; 155: 5868–77
Medaer R, Stinissen P, Truyen L, et al. Depletion of myelin-basic protein autoreactive T cells by T cell vaccination: pilot trial in multiple sclerosis. Lancet 1995; 346: 807–8
Stinissen P, Zhang J, Medaer R, et al. Vaccination with autoreactive T cell clones in multiple sclerosis: overview of immunological and clinical data. J Neurosci Res 1996; 45: 500–11
Vandenbark AA, Hashim G, Offner H. TCR peptide therapy in autoimmune diseases. Int Rev Immunol 1993; 9: 251–76
Lehman PV, Forsthuber T, Miller A, et al. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992; 358: 155–7
Salvetti M, Ristori G, D’Amato M, et al. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis. Eur J Immunol 1993; 23: 1232–9
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Medaer, R., Stinissen, P., Zhang, J. et al. Prospects for T Cell Vaccination in Multiple Sclerosis. BioDrugs 8, 1–5 (1997). https://doi.org/10.2165/00063030-199708010-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00063030-199708010-00001